Publication Name	World Journal of Gastroenterology
Manuscript ID	31909
Country	Taiwan

Received	2016-12-14 10:37
Peer-Review Started	2016-12-16 19:04
First Decision by Editorial Office Director
Return for Revision	2017-01-16 17:36
Revised	2017-02-12 12:06
Publication Fee Transferred	2017-04-10 12:12
Second Decision by Editor	2017-03-24 12:20
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2017-03-31 07:50
Articles in Press	2017-03-31 07:50
Edit the Manuscript by Language Editor	2017-04-21 07:49
Typeset the Manuscript	2017-05-09 17:38
Publish the Manuscript Online	2017-05-20 12:26

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Observational Study
Article Title	Relationship between use of selective serotonin reuptake inhibitors and irritable bowel syndrome: A population-based cohort study
Manuscript Source	Unsolicited Manuscript
All Author List	Wan-Tzu Lin, Yi-Jun Liao, Yen-Chun Peng, Chung-Hsin Chang, Ching-Heng Lin, Hong-Zen Yeh and Chi-Sen Chang
Funding Agency and Grant Number
Corresponding Author	Chi-Sen Chang, MD, PhD, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung 40705, Taiwan. changcs@vhgtc.gov.tw
Key Words	Brain-gut axis; Irritable bowel syndrome; Selective serotonin reuptake inhibitor
Core Tip	Selective serotonin reuptake inhibitor (SSRI) users were associated with a risk of subsequently diagnosed irritable bowel syndrome. The brain-gut axis may play a key role in this relationship. In clinical practice, physicians should pay attention to the gastrointestinal symptoms of patients with psychiatric disorders and SSRI use.
Publish Date	2017-05-20 12:26
Citation	Lin WZ, Liao YJ, Peng YC, Chang CH, Lin CH, Yeh HZ, Chang CS. Relationship between use of selective serotonin reuptake inhibitors and irritable bowel syndrome: A population-based cohort study. World J Gastroenterol 2017; 23(19): 3513-3521
URL	http://www.wjgnet.com/1007-9327/full/v23/i19/3513.htm
DOI	http://dx.doi.org/10.3748/wjg.v23.i19.3513

Full Article (PDF)	WJG-23-3513.pdf
Full Article (Word)	WJG-23-3513.doc
Manuscript File	31909-Review.docx
Answering Reviewers	31909-Answering reviewers.pdf
Audio Core Tip	31909-Audio core tip.mp3
Biostatistics Review Certificate	31909-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	31909-Conflict-of-interest statement.pdf
Copyright License Agreement	31909-Copyright assignment.pdf
Institutional Review Board Approval Form or Document	31909-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate	31909-Language certificate.pdf
Peer-review Report	31909-Peer-review(s).pdf
Scientific Misconduct Check	31909-Scientific misconduct check.pdf
Scientific Editor Work List	31909-Scientific editor work list.pdf